Clinical Trials Directory

Trials / Terminated

TerminatedNCT00708357

Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?

Status
Terminated
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
Male
Age
19 Years
Healthy volunteers
Accepted

Summary

Nitric oxide (NO) is a potent endothelium-derived vasodilatator that plays a major role in the control of ocular blood flow. Endothelial NO synthase (eNOS) is one of three isoforms of NOS producing NO through hydroxylation of L-arginine. The eNOS gene is located on the long arm of chromosome 7, and different polymorphic variations have been identified. These single nucleotide polymorphisms (sNP´s) have the ability to change transcription activity and therefore enzyme levels. Recent data indicate that the T -786C polymorphism (especially the homozygous variant) is associated with reduced eNOS activity and consequently impaired NO production. In the present study the investigators want to investigate if the T -786C eNOS gene polymorphism determines choroidal and optic nerve head blood flow.

Conditions

Interventions

TypeNameDescription
DRUGNG-monomethyl-L-arginineintravenous administration, bolus over 5 minutes, dosage 6mg/kg

Timeline

Start date
2005-05-01
Primary completion
2009-12-01
Completion
2013-01-01
First posted
2008-07-02
Last updated
2014-11-17

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00708357. Inclusion in this directory is not an endorsement.